John Reilly is an associate director in the Department of Global Discovery Chemistry at Novartis Institute of Biomedical Sciences, and is based in Basel, Switzerland. He currently leads the separations team, where there is a focus on providing purification and analytical characterization methodologies supporting a chemistry unit with over 250 chemists. An advocate of knowledge exchange, Reilly has had global roles in discovery and development during his time at Novartis and previously with Eli Lilly. He completed his MSc. At Birkbeck College in 1992 and his PhD in analytical science at Imperial College in 2002 after his initial BSc in chemistry at Reading University, Reading, UK in 1989. His research goals include the promotion of SFC’s new chromatographic characterization and purification methods and physicochemical affinity screens to investigate drug-like properties of molecules. Reilly has published more than 50 articles and has been a board member of The Chromatography Society. He has also been on the editorial board of Chromatography Today and American Journal of Modern Chromatography.
A new “one-shot” strategy for preparative chiral supercritical fluid chromatography (SFC) offers fast and effective approach to obtain and characterize individual enantiomers.
SFC delivers measurable cycle-time and solvent-use gains beyond chiral work, spanning biopharma and anti-doping applications, experts say.
